SBLX Form 4: CEO Joshua Silverman receives 220,513 options

Rhea-AI Filing Summary

StableX Technologies, Inc. (SBLX) reported an insider equity award. CEO and Director Joshua Silverman filed a Form 4 disclosing an employee stock option grant to purchase 220,513 shares of common stock at an exercise price of $6.25 per share on 10/31/2025. The filing lists the option grant price as $0.

Vesting terms: 75% vested on the grant date; the remaining 25% is scheduled to vest on December 31, 2025, contingent on continued service. Following the transaction, Silverman directly beneficially owns 220,513 derivative securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silverman Joshua

(Last) (First) (Middle)

1185 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
StableX Technologies, Inc. [ SBLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy	$6.25	10/31/2025		A		220,513		(1)	10/31/2035	Common Stock	220,513	$0	220,513	D

Explanation of Responses:

1. The stock options vest as follows: (i) 75% vested upon the date of grant; and (ii) 25% will vest on December 31, 2025, provided that the Reporting Person remains employed by or providing services to the Issuer on the applicable vesting date.

	/s/ Joshua Silverman	10/31/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SBLX report on this Form 4?

An employee stock option grant to CEO and Director Joshua Silverman for 220,513 options at an exercise price of $6.25 per share on 10/31/2025.

What are the vesting terms of the SBLX option grant?

75% vested on the grant date; 25% vests on December 31, 2025, subject to continued service.

How many derivative securities does the reporting person own after the transaction?

Joshua Silverman beneficially owns 220,513 derivative securities directly after the transaction.

What is the exercise price of the options reported by SBLX?

The options have an exercise price of $6.25 per share.

Who is the reporting person on the SBLX Form 4?

The reporting person is Joshua Silverman, who serves as Chief Executive Officer and Director.

When is the earliest transaction date reported?

The earliest transaction date reported is 10/31/2025.